
Celularity Inc. - Class A Common Stock
Acción · US1511902041 · CELU (XNAS)
2,07 USD
06.06.2025 19:59
Cotizaciones actuales de Celularity Inc. - Class A Common Stock
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
CELU
|
USD
|
06.06.2025 19:59
|
2,07 USD
| 1,92 USD
+7,81 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | -2,36 % | 23,58 % | 61,72 % | -10,78 % | -36,31 % | -97,93 % |
Perfil de la empresa para Celularity Inc. - Class A Common Stock Acción
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn's disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.
Datos de la empresa
Nombre Celularity Inc. - Class A Common Stock
Empresa Celularity Inc.
Símbolo CELU
Sitio web
https://www.celularity.com
Mercado principal
NASDAQ

ISIN US1511902041
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Dr. Robert Joseph Hariri M.D., Ph.D.
Capitalización de mercado 37 Mio
País Estados Unidos de América
Moneda USD
Empleados 0,1 T
Dirección 170 Park Avenue, 07932 Florham Park
Fecha de OPV 2019-08-08
Cambios de identificador
Fecha | De | A |
---|---|---|
19.07.2021 | GXGX | CELU |
Símbolos de cotización
Nombre | Símbolo |
---|---|
NASDAQ | CELU |
Otras acciones
Los inversores que tienen Celularity Inc. - Class A Common Stock también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.